<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK549920" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK549920/" /><meta name="ncbi_pagename" content="Tangier Disease - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Tangier Disease - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Tangier Disease" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/11/21" /><meta name="citation_author" content="John R Burnett" /><meta name="citation_author" content="Amanda J Hooper" /><meta name="citation_author" content="Sally PA McCormick" /><meta name="citation_author" content="Robert A Hegele" /><meta name="citation_pmid" content="31751110" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK549920/" /><meta name="citation_keywords" content="Analphalipoproteinemia" /><meta name="citation_keywords" content="Familial High-Density Lipoprotein Deficiency 1" /><meta name="citation_keywords" content="Primary Hypoalphalipoproteinemia 1" /><meta name="citation_keywords" content="Primary Hypoalphalipoproteinemia 1" /><meta name="citation_keywords" content="Familial High-Density Lipoprotein Deficiency 1" /><meta name="citation_keywords" content="Analphalipoproteinemia" /><meta name="citation_keywords" content="Phospholipid-transporting ATPase ABCA1" /><meta name="citation_keywords" content="ABCA1" /><meta name="citation_keywords" content="Tangier Disease" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Tangier Disease" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="John R Burnett" /><meta name="DC.Contributor" content="Amanda J Hooper" /><meta name="DC.Contributor" content="Sally PA McCormick" /><meta name="DC.Contributor" content="Robert A Hegele" /><meta name="DC.Date" content="2019/11/21" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK549920/" /><meta name="description" content="Tangier disease is characterized by severe deficiency or absence of high-density lipoprotein (HDL) in the circulation resulting in tissue accumulation of cholesteryl esters throughout the body, particularly in the reticuloendothelial system. The major clinical signs of Tangier disease include hyperplastic yellow-orange tonsils, hepatosplenomegaly, and peripheral neuropathy, which may be either relapsing-remitting or chronic progressive in nature. Rarer complications may include corneal opacities that typically do not affect vision, premature atherosclerotic coronary artery disease occurring in the sixth and seventh decades of life (not usually before age 40 years), and mild hematologic manifestations, such as mild thrombocytopenia, reticulocytosis, stomatocytosis, or hemolytic anemia. The clinical expression of Tangier disease is variable, with some affected individuals only showing biochemical perturbations." /><meta name="og:title" content="Tangier Disease" /><meta name="og:type" content="book" /><meta name="og:description" content="Tangier disease is characterized by severe deficiency or absence of high-density lipoprotein (HDL) in the circulation resulting in tissue accumulation of cholesteryl esters throughout the body, particularly in the reticuloendothelial system. The major clinical signs of Tangier disease include hyperplastic yellow-orange tonsils, hepatosplenomegaly, and peripheral neuropathy, which may be either relapsing-remitting or chronic progressive in nature. Rarer complications may include corneal opacities that typically do not affect vision, premature atherosclerotic coronary artery disease occurring in the sixth and seventh decades of life (not usually before age 40 years), and mild hematologic manifestations, such as mild thrombocytopenia, reticulocytosis, stomatocytosis, or hemolytic anemia. The clinical expression of Tangier disease is variable, with some affected individuals only showing biochemical perturbations." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK549920/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/tangier/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK549920/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE88BD1FE03F999100000000092B0345.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK549920_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK549920_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/tubb4a-leuk/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tetra-amelia/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK549920_"><span class="title" itemprop="name">Tangier Disease</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: Analphalipoproteinemia, Familial High-Density Lipoprotein Deficiency 1, Primary Hypoalphalipoproteinemia 1</div><p class="contrib-group"><span itemprop="author">John R Burnett</span>, MB ChB, MD, PhD, FRCPA, <span itemprop="author">Amanda J Hooper</span>, PhD, <span itemprop="author">Sally PA McCormick</span>, PhD, and <span itemprop="author">Robert A Hegele</span>, MD, FRCPC, FACP.</p><a data-jig="ncbitoggler" href="#__NBK549920_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK549920_ai__"><div class="contrib half_rhythm"><span itemprop="author">John R Burnett</span>, MB ChB, MD, PhD, FRCPA<div class="affiliation small">Department of Clinical Biochemistry<br />Royal Perth Hospital &#x00026; Fiona Stanley Hospital Network<br />PathWest Laboratory Medicine WA;<br />School of Medicine<br />Faculty of Health &#x00026; Medical Sciences<br />University of Western Australia<br />Perth, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.vog.aw.htlaeh@ttenrub.nhoj" class="oemail">ua.vog.aw.htlaeh@ttenrub.nhoj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Amanda J Hooper</span>, PhD<div class="affiliation small">Department of Clinical Biochemistry<br />Royal Perth Hospital &#x00026; Fiona Stanley Hospital Network<br />PathWest Laboratory Medicine WA;<br />School of Medicine<br />Faculty of Health &#x00026; Medical Sciences<br />University of Western Australia<br />Perth, Australia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ua.vog.aw.htlaeh@repooh.adnama" class="oemail">ua.vog.aw.htlaeh@repooh.adnama</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Sally PA McCormick</span>, PhD<div class="affiliation small">Department of Biochemistry<br />University of Otago<br />Dunedin, New Zealand<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="zn.ca.ogato@kcimroccm.yllas" class="oemail">zn.ca.ogato@kcimroccm.yllas</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Robert A Hegele</span>, MD, FRCPC, FACP<div class="affiliation small">Departments of Medicine and Biochemistry<br />Schulich School of Medicine and Robarts Research Institute<br />Western University<br />London, Ontario, Canada<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ac.strabor@elegeh" class="oemail">ac.strabor@elegeh</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 21, 2019</span>.</p><p><em>Estimated reading time: 12 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="tangier.Summary" itemprop="description"><h2 id="_tangier_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Tangier disease is characterized by severe deficiency or absence of high-density lipoprotein (HDL) in the circulation resulting in tissue accumulation of cholesteryl esters throughout the body, particularly in the reticuloendothelial system. The major clinical signs of Tangier disease include hyperplastic yellow-orange tonsils, hepatosplenomegaly, and peripheral neuropathy, which may be either relapsing-remitting or chronic progressive in nature. Rarer complications may include corneal opacities that typically do not affect vision, premature atherosclerotic coronary artery disease occurring in the sixth and seventh decades of life (not usually before age 40 years), and mild hematologic manifestations, such as mild thrombocytopenia, reticulocytosis, stomatocytosis, or hemolytic anemia. The clinical expression of Tangier disease is variable, with some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals only showing biochemical perturbations.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of Tangier disease is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with absent or extremely low HDL-cholesterol and apo A-I levels and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ABCA1</i> identified by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Tonsillectomy in those with airway obstruction or mass symptoms; transient bracing (such as ankle-foot orthosis) and exercise for those with peripheral neuropathy; corneal transplantation for corneal opacities that interfere with daily living; standard treatment for hepatosplenomegaly, coronary artery disease, severe thrombocytopenia, and severe hemolytic anemia.</p><p><i>Prevention of primary manifestations:</i> Mitigation of cardiovascular risk factors, including improvement of plasma lipid profiles using statin therapy and a low-fat diet.</p><p><i>Surveillance</i>: Assessment for hepatosplenomegaly by physical examination and imaging at each visit; neurology and ophthalmology evaluations annually; cardiovascular risk assessment of atherosclerotic plaque burden annually beginning in adulthood; complete blood count with differential as clinically indicated.</p><p><i>Agents/circumstances to avoid</i>: Obesity (which makes walking more difficult); medications that are toxic or potentially toxic to those who are predisposed to the development of peripheral neuropathy; contact sports in those with hepatosplenomegaly.</p><p><i>Evaluation of relatives at risk:</i> It is appropriate to measure a lipid profile (total cholesterol, HDL-cholesterol, triglyceride, and calculated LDL-cholesterol) and apo A-I concentration in at-risk sibs to identify as early as possible those who would benefit from appropriate treatment or measures to prevent disease complications.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Tangier disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Most parents are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. At conception each sib has a 25% chance of being unaffected, a 50% chance of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> (with no overt clinical manifestations, but with plasma HDL-cholesterol concentrations that are ~50% of normal), and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variants in the family are known.</p></div></div><div id="tangier.Diagnosis"><h2 id="_tangier_Diagnosis_">Diagnosis</h2><p>Formal clinical diagnostic criteria for Tangier disease have not been published.</p><div id="tangier.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Tangier disease <b>should be suspected</b> in individuals with the following clinical and supportive laboratory findings.</p><p><b>Clinical findings</b></p><ul><li class="half_rhythm"><div>Enlarged tonsils that are yellow and/or orange in children and young adults</div></li><li class="half_rhythm"><div>Peripheral neuropathy</div></li><li class="half_rhythm"><div>Hepatomegaly and/or splenomegaly</div></li><li class="half_rhythm"><div>Corneal opacities</div></li><li class="half_rhythm"><div>Coronary artery disease</div></li><li class="half_rhythm"><div>Lymphadenopathy</div></li><li class="half_rhythm"><div>Blood disorders (especially thrombocytopenia)</div></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div>Major findings:</div><ul><li class="half_rhythm"><div>Very low plasma HDL-cholesterol concentration, typically &#x0003c;5 mg/dL (0.125 mmol/L), rarely 5-10 mg/dL</div></li><li class="half_rhythm"><div>Very low or absent apo A-I concentration, usually &#x0003c;30 mg/dL (typically &#x0003c;5 mg/dL)</div></li><li class="half_rhythm"><div>Small or absent alpha band on lipoprotein electrophoresis</div></li></ul></li><li class="half_rhythm"><div>Other laboratory findings:</div><ul><li class="half_rhythm"><div>Low plasma total cholesterol concentration, typically &#x0003c;150 mg/dL (4 mmol/L)</div></li><li class="half_rhythm"><div>Mild-to-moderate hypertriglyceridemia, up to 400 mg/dL (4.5 mmol/L)</div></li><li class="half_rhythm"><div>Decreased LDL-cholesterol concentration</div></li><li class="half_rhythm"><div>Small beta or broad pre-beta band on lipoprotein electrophoresis</div></li></ul></li></ul></div><div id="tangier.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Tangier disease <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with absent or extremely low HDL-cholesterol and apo A-I levels and <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ABCA1</i> identified on <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK549920/table/tangier.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figtangierTmoleculargenetictestingused" rid-ob="figobtangierTmoleculargenetictestingused">Table 1</a>).</p><p>Note: If clinical <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> cannot be performed, the presence of accumulation of cholesterol esters in tissue biopsies in an individual with typical clinical features of Tangier disease can be considered.</p><p>When the phenotypic and laboratory findings suggest the diagnosis of Tangier disease, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>ABCA1</i> detects small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions/duplications are not detected. Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> first. If only one or no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is found, perform gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> to detect intragenic deletions or duplications.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ABCA1</i> and other genes of interest (see <a href="#tangier.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For this disorder a multigene panel that also includes deletion/duplication analysis is recommended (see <a class="figpopup" href="/books/NBK549920/table/tangier.T.molecular_genetic_testing_used/?report=objectonly" target="object" rid-figpopup="figtangierTmoleculargenetictestingused" rid-ob="figobtangierTmoleculargenetictestingused">Table 1</a>).</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="tangier.T.molecular_genetic_testing_used" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Tangier Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK549920/table/tangier.T.molecular_genetic_testing_used/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tangier.T.molecular_genetic_testing_used_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tangier.T.molecular_genetic_testing_used_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_tangier.T.molecular_genetic_testing_used_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_tangier.T.molecular_genetic_testing_used_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_tangier.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCA1</i></td><td headers="hd_h_tangier.T.molecular_genetic_testing_used_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_tangier.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90%</td></tr><tr><td headers="hd_h_tangier.T.molecular_genetic_testing_used_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>4</sup></td><td headers="hd_h_tangier.T.molecular_genetic_testing_used_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;10%&#x000a0;<sup>5</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="tangier.TF.1.1"><p class="no_margin">See <a href="/books/n/gene/tangier-dz/#tangier-dz.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="tangier.TF.1.2"><p class="no_margin">See <a href="#tangier.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="tangier.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="tangier.TF.1.4"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>5. </dt><dd><div id="tangier.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#tangier.REF.dron.2018.1529">Dron et al [2018]</a></p></div></dd></dl></div></div></div></div></div><div id="tangier.Clinical_Characteristics"><h2 id="_tangier_Clinical_Characteristics_">Clinical Characteristics</h2><div id="tangier.Clinical_Description"><h3>Clinical Description</h3><p>Tangier disease is characterized by severe deficiency or absence of high-density lipoprotein (HDL) in the circulation resulting in tissue accumulation of cholesteryl esters throughout the body, particularly in the reticuloendothelial system [<a class="bk_pop" href="#tangier.REF.assmann.2001">Assmann et al 2001</a>]. The major clinical signs of Tangier disease include hyperplastic yellow-orange tonsils, peripheral neuropathy, and hepatosplenomegaly. The clinical course of neuropathy may be either relapsing-remitting or chronic progressive [<a class="bk_pop" href="#tangier.REF.mercan.2018.88">Mercan et al 2018</a>]. However, the clinical expression of Tangier disease is variable, with some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals only showing biochemical perturbation.</p><p><b>Histiocytic manifestations</b></p><ul><li class="half_rhythm"><div>Hyperplastic yellow-orange palatine and pharyngeal tonsils are typically first noted in late childhood or adolescence. This finding does not usually cause any symptoms; however, it may occasionally cause difficulty breathing or swallowing, recurrent ear or sinus infections, or obstructive sleep apnea.</div></li><li class="half_rhythm"><div>Hepatomegaly and/or splenomegaly presents more commonly in adulthood.</div></li><li class="half_rhythm"><div>Orange-brown focal deposits of the intestinal and rectal mucosa may be seen on colonoscopy, but typically do not cause any symptoms.</div></li><li class="half_rhythm"><div>Lymphadenopathy may be found in the thoracic, axillary, and cervical regions of the body.</div></li></ul><p><b>Neurologic manifestations.</b> Peripheral neuropathy, the clinical course of which is commonly benign, can be relapsing-remitting with sensory abnormalities but in some individuals can be progressive. Findings may include the following:</p><ul><li class="half_rhythm"><div>Multifocal mono- or polyneuropathy (monophasic or relapsing-remitting pattern)</div></li><li class="half_rhythm"><div>Syringomyelia-like neuropathy (slowly progressive weakness, muscle wasting, and loss of pain and temperature sensation mainly affecting the upper extremities)</div></li><li class="half_rhythm"><div>Subclinical or distal symmetric polyneuropathy (rare)</div></li></ul><p><b>Ophthalmologic manifestations.</b> Corneal opacities, which are diffuse or dot-like, occur later in life and generally do not affect vision.</p><p><b>Cardiac manifestations.</b> Premature atherosclerotic coronary artery disease may develop in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, usually in the 50s and 60s [<a class="bk_pop" href="#tangier.REF.schaefer.2010.289">Schaefer et al 2010</a>], and usually not before age 40 years [<a class="bk_pop" href="#tangier.REF.burnett.1994.923">Burnett et al 1994</a>]. Some affected individuals may have heart valve involvement.</p><p><b>Hematologic manifestations</b></p><ul><li class="half_rhythm"><div>Mild thrombocytopenia</div></li><li class="half_rhythm"><div>Reticulocytosis</div></li><li class="half_rhythm"><div>Stomatocytosis</div></li><li class="half_rhythm"><div>Hemolytic anemia</div></li></ul><p><b>Dermatologic manifestations.</b> The skin lesions of Tangier disease have not been extensively reported. However, prurigo nodularis, skin ulcer, and painless scald or burn scars have been reported in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p><p><b>Prognosis.</b> The prognosis in Tangier disease is usually good and depends mainly on the progression of peripheral neuropathy and/or atherosclerosis. Individuals with Tangier disease have a moderately increased risk of coronary artery disease (see <b>Cardiac manifestations</b>), which can be managed with conventional preventive therapies [<a class="bk_pop" href="#tangier.REF.schaefer.2010.289">Schaefer et al 2010</a>, <a class="bk_pop" href="#tangier.REF.schaefer.2016.97">Schaefer et al 2016</a>].</p></div><div id="tangier.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Given the small number of individuals with Tangier disease reported in the literature, reliable data on <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> are lacking.</p></div><div id="tangier.Prevalence"><h3>Prevalence</h3><p>With the exception of small founder populations (e.g., Tangier Island, Virginia, after which the disorder is named), Tangier disease is rare; fewer than 100 cases have been published.</p></div></div><div id="tangier.Genetically_Related_Allelic_Diso"><h2 id="_tangier_Genetically_Related_Allelic_Diso_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ABCA1</i>.</p></div><div id="tangier.Differential_Diagnosis"><h2 id="_tangier_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Artefactual and secondary causes of severe HDL deficiency.</b> In the setting of an extremely low HDL-cholesterol in the absence of hypertriglyceridemia, artefactual causes (e.g., paraproteinemia) and secondary causes (e.g., androgenic anabolic steroids, paradoxic response to PPAR agonists, malaria, HIV infection, malignancy, liver disease) should be excluded [<a class="bk_pop" href="#tangier.REF.rader.2012.3399">Rader &#x00026; deGoma 2012</a>].</p><p><b>Hereditary disorders with severe HDL deficiency.</b> See <a class="figpopup" href="/books/NBK549920/table/tangier.T.disorders_with_severe_hdl_defi/?report=objectonly" target="object" rid-figpopup="figtangierTdisorderswithseverehdldefi" rid-ob="figobtangierTdisorderswithseverehdldefi">Table 2</a>.</p><div id="tangier.T.disorders_with_severe_hdl_defi" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Disorders with Severe HDL Deficiency to Consider in the Differential Diagnosis of Tangier Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK549920/table/tangier.T.disorders_with_severe_hdl_defi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tangier.T.disorders_with_severe_hdl_defi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Distinguishing Features</th></tr></thead><tbody><tr><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Apo A-I deficiency&#x000a0;<sup>1</sup></td><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>APOA1</i></td><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma apo A-I is undetectable (compared w/very low plasma apo A-I in Tangier disease)&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LCAT deficiency&#x000a0;<sup>1</sup><br />(OMIM <a href="https://omim.org/entry/245900" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">245900</a>)</td><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><i>LCAT</i></td><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Marked corneal opacification (plus renal disease in individuals w/complete LCAT deficiency)&#x000a0;<sup>2</sup></td></tr><tr><td headers="hd_h_tangier.T.disorders_with_severe_hdl_defi_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fish eye disease&#x000a0;<sup>1</sup><br />(OMIM <a href="https://omim.org/entry/136120" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">136120</a>)</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Apo A-I = apolipoprotein A-I; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; LCAT = lecithin cholesterol acyltransferase; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt>1. </dt><dd><div id="tangier.TF.2.1"><p class="no_margin"><a class="bk_pop" href="#tangier.REF.oldoni.2014.124">Oldoni et al [2014]</a></p></div></dd><dt>2. </dt><dd><div id="tangier.TF.2.2"><p class="no_margin">Only the biochemical perturbation is expressed in individuals who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>APOA1</i> or <i>LCAT</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; the biochemical perturbation can be indistinguishable from that observed in individuals heterozygous for an <i>ABCA1</i> pathogenic variant [<a class="bk_pop" href="#tangier.REF.geller.2018.2421">Geller et al 2018</a>].</p></div></dd></dl></div></div></div></div><div id="tangier.Management"><h2 id="_tangier_Management_">Management</h2><div id="tangier.Evaluations_Following_Initial_Di"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Tangier disease, the evaluations summarized in <a class="figpopup" href="/books/NBK549920/table/tangier.T.recommended_evaluations_follow/?report=objectonly" target="object" rid-figpopup="figtangierTrecommendedevaluationsfollow" rid-ob="figobtangierTrecommendedevaluationsfollow">Table 3</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="tangier.T.recommended_evaluations_follow" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with Tangier Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK549920/table/tangier.T.recommended_evaluations_follow/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tangier.T.recommended_evaluations_follow_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Histiocytic</b></td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physical examination to assess tonsillar hypertrophy</td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to otolaryngologist.</td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Abdominal ultrasonography to assess for hepatosplenomegaly</td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Nerve conduction studies &#x00026; electromyography to determine presence &#x00026;/or extent of peripheral neuropathy</td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to neurologist.</td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation to assess for corneal opacities</td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to ophthalmologist.</td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma lipid profile (total cholesterol, triglycerides, LDL-, HDL-cholesterol) &#x00026; apo A-I concentration</td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to cardiologist.</td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Noninvasive imaging of carotid plaque burden by duplex ultrasonography</td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Coronary calcium score&#x000a0;<sup>1</sup> &#x00026;/or CT coronary angiography to assess for coronary atherosclerosis</td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hematologic</b></td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete blood count w/differential &#x00026; peripheral blood film (also known as a blood smear)</td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider referral to hematologist.</td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dermatologic</b></td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dermatologic consultation if indicated</td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Miscellaneous/</b><br /><b>Other</b></td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_tangier.T.recommended_evaluations_follow_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="tangier.TF.3.1"><p class="no_margin">A cardiac calcium score involves a noninvasive CT scan of the heart that is able to measure the amount of calcified plaque in the coronary arteries. This score is used to estimate the risk an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has of developing coronary artery disease.</p></div></dd></dl></div></div></div></div><div id="tangier.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="tangier.T.treatment_of_manifestations_in" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with Tangier Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK549920/table/tangier.T.treatment_of_manifestations_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tangier.T.treatment_of_manifestations_in_lrgtbl__"><table><thead><tr><th id="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Enlarged hyperplastic</b><br /><b>palatine tonsils</b></td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tonsillectomy</td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider if tonsils cause airway obstruction or mass symptoms.</td></tr><tr><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hepatosplenomegaly</b></td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment</td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Incl standard precautions such as avoidance of high-impact sports or activities that could lead to splenic rupture. Abdominal masses may complicate splenectomy.</td></tr><tr><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Peripheral</b><br /><b>neuropathy</b></td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinically proven effective treatments are not yet available.</td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Transient bracing (e.g., w/wrist splint or ankle-foot orthosis) may be useful.</td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Those w/residual foot drop may need to use an ankle-foot orthosis permanently.</td></tr><tr><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Exercise as appropriate to individual's capacity</td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To maintain balance &#x00026; strength</td></tr><tr><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Corneal opacification</b></td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Corneal transplantation</td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consider if this interferes w/daily living.</td></tr><tr><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Coronary artery</b><br /><b>disease</b></td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment, incl use of dietary &#x00026; pharmacologic therapies</td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See <a href="#tangier.Prevention_of_Primary_Manifestat">Prevention of Primary Manifestations</a>.</td></tr><tr><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Thrombocytopenia /</b><br /><b>Hemolytic anemia</b></td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard treatment, if severe</td><td headers="hd_h_tangier.T.treatment_of_manifestations_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="tangier.Prevention_of_Primary_Manifestat"><h3>Prevention of Primary Manifestations</h3><p>Mitigation of cardiovascular risk factors (including LDL-cholesterol concentrations using statin therapy and a low-fat diet) is indicated.</p></div><div id="tangier.Surveillance"><h3>Surveillance</h3><div id="tangier.T.recommended_surveillance_for_i" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with Tangier Disease</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK549920/table/tangier.T.recommended_surveillance_for_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tangier.T.recommended_surveillance_for_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Histiocytic</b></td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Assessment for hepatosplenomegaly by physical examination &#x00026; abdominal imaging modalities</td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At each visit</td></tr><tr><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Neurologic</b></td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neurologic evaluation</td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmologic</b></td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ophthalmologic evaluation</td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiovascular</b></td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiovascular risk assessment, incl noninvasive assessment of atherosclerotic plaque burden&#x000a0;<sup>1</sup></td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually beginning in early adulthood</td></tr><tr><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hematologic</b></td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Complete blood count w/differential</td><td headers="hd_h_tangier.T.recommended_surveillance_for_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">As clinically indicated</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="tangier.TF.5.1"><p class="no_margin">Duplex coronary ultrasonography (see <a class="figpopup" href="/books/NBK549920/table/tangier.T.recommended_evaluations_follow/?report=objectonly" target="object" rid-figpopup="figtangierTrecommendedevaluationsfollow" rid-ob="figobtangierTrecommendedevaluationsfollow">Table 3</a>)</p></div></dd></dl></div></div></div></div><div id="tangier.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div>Obesity, because it makes walking more difficult</div></li><li class="half_rhythm"><div>Medications that are toxic or potentially toxic to persons who are predisposed to the development of peripheral neuropathy, such as vincristine or taxols (paclitaxel)</div></li><li class="half_rhythm"><div>Contact sports, in those with hepatosplenomegaly</div></li></ul></div><div id="tangier.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div>A lipid profile (including total cholesterol, HDL-cholesterol, triglyceride, and calculated LDL-cholesterol) and apo A-I concentration;</div></li><li class="half_rhythm"><div>Molecular genetic testing if the pathogenic variants in the family are known.</div></li></ul><p>See <a href="#tangier.Related_Genetic_Counseling_Issue">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="tangier.Pregnancy_Management"><h3>Pregnancy Management</h3><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for information on medication use during pregnancy.</p></div><div id="tangier.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="tangier.Genetic_Counseling"><h2 id="_tangier_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="tangier.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Tangier disease is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner. Heterozygous carriers of an <i>ABCA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are asymptomatic but tend to have hypoalphalipoproteinemia (HDL-cholesterol concentrations that are ~50% of normal).</p></div><div id="tangier.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child are obligate heterozygotes (i.e., carriers of one <i>ABCA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>).</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and have no clinical manifestations, but they may have plasma HDL-cholesterol concentrations that are approximately one half of normal.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has a 25% chance of being affected, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Heterozygotes (carriers) are asymptomatic and have no clinical manifestations, but often have plasma HDL-cholesterol concentrations that are approximately one-half of normal.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The offspring of an individual with Tangier disease are obligate heterozygotes (carriers) for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ABCA1</i>.</p><p><b>Other family members.</b> Each sib of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents is at a 50% risk of being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ABCA1</i>.</p></div><div id="tangier.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing for at-risk relatives requires prior identification of the <i>ABCA1</i> pathogenic variants in the family.</p></div><div id="tangier.Related_Genetic_Counseling_Issue"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#tangier.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="tangier.Prenatal_Testing_and_Preimplanta"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Once the <i>ABCA1</i> pathogenic variants have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-testing/">preimplantation genetic testing</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="tangier.Resources"><h2 id="_tangier_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="https://ghr.nlm.nih.gov/condition/tangier-disease" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Tangier disease</a></div></li></ul></div><div id="tangier.Molecular_Genetics"><h2 id="_tangier_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="tangier.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Tangier Disease: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK549920/table/tangier.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tangier.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_tangier.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_tangier.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_tangier.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_tangier.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_tangier.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_tangier.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_tangier.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/19" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ABCA1</i></a></td><td headers="hd_b_tangier.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=19" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q31<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_tangier.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/O95477" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Phospholipid-transporting ATPase ABCA1</a></td><td headers="hd_b_tangier.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/ABCA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ABCA1 @ LOVD</a></td><td headers="hd_b_tangier.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ABCA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ABCA1</a></td><td headers="hd_b_tangier.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ABCA1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ABCA1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="tangier.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="tangier.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Tangier Disease (<a href="/omim/205400,600046" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK549920/table/tangier.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tangier.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/205400" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">205400</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TANGIER DISEASE; TGD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/600046" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">600046</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1</td></tr></tbody></table></div></div><div id="tangier.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><b>Introduction.</b> The 49-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>ABCA1</i> encodes ABCA1, a 2,261-amino acid member of the ATP-binding cassette transporter family, which is a large group of transporters involved in the transfer of different hydrophobic compounds across cell membranes. ABCA1 is a flippase, which promotes movement of lipid (chiefly unesterified cholesterol, but also phosphatidylcholine) across the cell membrane from inside to outside [<a class="bk_pop" href="#tangier.REF.quazi.2011.265">Quazi &#x00026; Molday 2011</a>]. ABCA1 facilitates the formation of HDL particles by transferring cholesterol and phospholipids onto apo A-I within nascent HDL, and promotes the efflux of cholesterol from vascular endothelial cells and macrophages [<a class="bk_pop" href="#tangier.REF.qian.2017.1228">Qian et al 2017</a>]. Small apoA-I-containing particles are prone to degradation in the kidney. Defects in ABCA1 therefore reduce circulating HDL-cholesterol concentrations and result in the accumulation of cholesteryl esters in reticuloendothelial cells throughout the body (e.g., as in tonsils, lymph nodes, spleen, liver, and intestinal mucosa) as well as in an increased risk of coronary heart disease. Mild to moderate hypertriglyceridemia occurs because there is an increase in large triglyceride-rich VLDL production as a result of dysregulation related to the absence of ABCA1 [<a class="bk_pop" href="#tangier.REF.liu.2012.770">Liu et al 2012</a>].</p><p><b>Mechanism of disease causation.</b> Tangier disease is caused by <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>ABCA1</i>, resulting in reduced ABCA1 synthesis or activity. Loss-of-function <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants may disrupt binding with apo A-I or ATP or trafficking of the ABCA1 protein to the cell membrane. Large-scale deletions are rare but may affect a single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>, multiple exons, or the entire <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> [<a class="bk_pop" href="#tangier.REF.dron.2018.1529">Dron et al 2018</a>].</p><div id="tangier.T.notable_abca1_pathogenic_varia" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Notable <i>ABCA1</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK549920/table/tangier.T.notable_abca1_pathogenic_varia/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__tangier.T.notable_abca1_pathogenic_varia_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_005502.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005502<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_005493.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005493<wbr style="display:inline-block"></wbr>​.2</a></td><td headers="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1824delG</td><td headers="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.(Thr609ArgfsTer27)</td><td headers="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Founder variants on Tangier Island [<a class="bk_pop" href="#tangier.REF.bodzioch.1999.347">Bodzioch et al 1999</a>, <a class="bk_pop" href="#tangier.REF.rust.1999.352">Rust et al 1999</a>]</td></tr><tr><td headers="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.1881C&#x0003e;G</td><td headers="hd_h_tangier.T.notable_abca1_pathogenic_varia_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Tyr627Ter</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div></div></div><div id="tangier.References"><h2 id="_tangier_References_">References</h2><div id="tangier.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.assmann.2001">Assmann G, von Eckardstein A, Brewer HB Jr. Familial analphalipoproteinemia: Tangier disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <em>The Metabolic and Molecular Bases of Inherited Disease</em>. 8 ed. Vol 2. New York, NY: McGraw-Hill; 2001:2937-80.</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.bodzioch.1999.347">Bodzioch M, Ors&#x000f3; E, Klucken J, Langmann T, B&#x000f6;ttcher A, Diederich W, Drobnik W, Barlage S, B&#x000fc;chler C, Porsch-Ozc&#x000fc;r&#x000fc;mez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">22</span>:347–51.</span> [<a href="/pubmed/10431237" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10431237</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.burnett.1994.923">Burnett JR, Law AJJ, Yeong ML, Crooke MJ, Sharma AK. Severe aortic stenosis and atherosclerosis in a young man with Tangier disease. <span><span class="ref-journal">Am J Cardiol. </span>1994;<span class="ref-vol">73</span>:923–5.</span> [<a href="/pubmed/8184829" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8184829</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.dron.2018.1529">Dron JS, Wang J, Berberich AJ, Iacocca MA, Cao H, Yang P, Knoll J, Tremblay K, Brisson D, Netzer C, Gouni-Berthold I, Gaudet D, Hegele RA. Large-scale deletions of the ABCA1 gene in patients with hypoalphalipoproteinemia. <span><span class="ref-journal">J Lipid Res. </span>2018;<span class="ref-vol">59</span>:1529–35.</span> [<a href="/pmc/articles/PMC6071767/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6071767</span></a>] [<a href="/pubmed/29866657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29866657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.geller.2018.2421">Geller AS, Polisecki EY, Diffenderfer MR, Asztalos BF, Karathanasis SK, Hegele RA, Schaefer EJ. Genetic and secondary causes of severe HDL deficiency and cardiovascular disease. <span><span class="ref-journal">J Lipid Res. </span>2018;<span class="ref-vol">59</span>:2421–35.</span> [<a href="/pmc/articles/PMC6277167/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6277167</span></a>] [<a href="/pubmed/30333156" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 30333156</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.liu.2012.770">Liu M, Chung S, Shelness GS, Parks JS. Hepatic ABCA1 and VLDL triglyceride production. <span><span class="ref-journal">Biochim Biophys Acta. </span>2012;<span class="ref-vol">1821</span>:770–7.</span> [<a href="/pmc/articles/PMC3272310/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3272310</span></a>] [<a href="/pubmed/22001232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22001232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.mercan.2018.88">Mercan M, Yayla V, Altinay S, Seyhan S. Peripheral neuropathy in Tangier disease: a literature review and assessment. <span><span class="ref-journal">J Peripher Nerv Syst. </span>2018;<span class="ref-vol">23</span>:88–98.</span> [<a href="/pubmed/29582519" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29582519</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.oldoni.2014.124">Oldoni F, Sinke RJ, Kuivenhoven JA. Mendelian disorders of high-density lipoprotein metabolism. <span><span class="ref-journal">Circ Res. </span>2014;<span class="ref-vol">114</span>:124–42.</span> [<a href="/pubmed/24385507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24385507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.qian.2017.1228">Qian H, Zhao X, Cao P, Lei J, Yan N, Gong X. Structure of the human lipid exporter ABCA1. <span><span class="ref-journal">Cell. </span>2017;<span class="ref-vol">169</span>:1228–1239.e10.</span> [<a href="/pubmed/28602350" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28602350</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.quazi.2011.265">Quazi F, Molday RS. Lipid transport by mammalian ABC proteins. <span><span class="ref-journal">Essays Biochem. </span>2011;<span class="ref-vol">50</span>:265–90.</span> [<a href="/pubmed/21967062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21967062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.rader.2012.3399">Rader DJ, deGoma EM. Approach to the patient with extremely low HDL-cholesterol. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2012;<span class="ref-vol">97</span>:3399–407.</span> [<a href="/pmc/articles/PMC3462950/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3462950</span></a>] [<a href="/pubmed/23043194" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23043194</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.rust.1999.352">Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Den&#x000e8;fle P, Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">22</span>:352–5.</span> [<a href="/pubmed/10431238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10431238</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.schaefer.2016.97">Schaefer EJ, Anthanont P, Diffenderfer MR, Polisecki E, Asztalos BF. Diagnosis and treatment of high density lipoprotein deficiency. <span><span class="ref-journal">Prog Cardiovasc Dis. </span>2016;<span class="ref-vol">59</span>:97–106.</span> [<a href="/pmc/articles/PMC5331615/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5331615</span></a>] [<a href="/pubmed/27565770" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27565770</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="tangier.REF.schaefer.2010.289">Schaefer EJ, Santos RD, Asztalos BF. Marked HDL deficiency and premature coronary heart disease. <span><span class="ref-journal">Curr Opin Lipidol. </span>2010;<span class="ref-vol">21</span>:289–97.</span> [<a href="/pubmed/20616715" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20616715</span></a>]</div></li></ul></div></div><div id="tangier.Chapter_Notes"><h2 id="_tangier_Chapter_Notes_">Chapter Notes</h2><div id="tangier.Author_Notes"><h3>Author Notes</h3><p><a href="http://www.lipidgeneticsclinic.ca" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lipid Genetics Clinic</a></p><p>Robert A Hegele directs a tertiary referral lipid speciality clinic and a genomics core facility (<a href="http://www.lrgc.ca/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">London Regional Genomics Centre</a>) in London, Ontario, Canada, and has a research program in genetics of dyslipidemias and related metabolic disorders.</p></div><div id="tangier.Acknowledgments"><h3>Acknowledgments</h3><p>Robert A Hegele is supported by the Jacob J Wolfe Distinguished Medical Research Chair, the Edith Schulich Vinet Canada Research Chair in Human Genetics, the Martha G Blackburn Chair in Cardiovascular Research, and operating grants from the Canadian Institutes of Health Research (Foundation Grant) and the Heart and Stroke Foundation of Ontario (G-18-0022147).</p></div><div id="tangier.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>21 November 2019 (ma) Review posted live</div></li><li class="half_rhythm"><div>18 April 2019 (jb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK549920</span><span class="label">PMID: <a href="/pubmed/31751110" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31751110</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/tubb4a-leuk/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/tetra-amelia/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK549920&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK549920/?report=reader">PubReader</a></li><li><a href="/books/NBK549920/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK549920" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK549920" style="display:none" title="Cite this Page"><div class="bk_tt">Burnett JR, Hooper AJ, McCormick SPA, et al. Tangier Disease. 2019 Nov 21. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK549920/pdf/Bookshelf_NBK549920.pdf">PDF version of this page</a> (423K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#tangier.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#tangier.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#tangier.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#tangier.Genetically_Related_Allelic_Diso" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#tangier.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#tangier.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#tangier.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#tangier.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#tangier.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#tangier.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#tangier.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=19[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ABCA1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=4882442" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4882442" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4882442" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=4882442" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/30358967" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Abetalipoproteinemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Abetalipoproteinemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Burnett JR, Hooper AJ, Hegele RA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24404629" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Hypercholesterolemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Familial Hypercholesterolemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Youngblom E, Pariani M, Knowles JW. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26225414" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lysosomal Acid Lipase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Lysosomal Acid Lipase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Hoffman EP, Barr ML, Giovanni MA, Murray MF. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301446" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gaucher Disease</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Gaucher Disease<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pastores GM, Hughes DA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/22913675" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Tangier disease: epidemiology, pathophysiology, and management.</a><span class="source">[Am J Cardiovasc Drugs. 2012]</span><div class="brieflinkpop offscreen_noflow">Tangier disease: epidemiology, pathophysiology, and management.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Puntoni M, Sbrana F, Bigazzi F, Sampietro T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Cardiovasc Drugs. 2012 Oct 1; 12(5):303-11. </em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31751110" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31751110" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041167dde08911699aa0c8">Tangier Disease - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Tangier Disease - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:48:23-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE88BD1FE03F999100000000092B0345&amp;ncbi_session=CE88BD1FE0411671_2347SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK549920%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK549920&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK549920/&amp;ncbi_pagename=Tangier Disease - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE88BD1FE0411671_2347SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>